U.S. Water Utilities Stock News

If you are wondering whether Origin Bancorp's current share price reflects solid value or hidden risk, it helps to start by lining up the recent performance with what you are actually paying for the business. The stock last closed at US$39.70, with returns of 1.1% over 7 days, 2.1% over 30 days, 5.5% year to date, 13.1% over 1 year, 8.7% over 3 years, and 47.1% over 5 years. This gives useful context before comparing the price to fundamentals. Recent coverage has focused on Origin Bancorp's...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Rivulet Entertainment (OTCPK:RIVF) opened 2026 with a quiet top line and a deeper loss, reporting Q1 total revenue of US$0 and a net loss of US$0.97 million, which translated to basic EPS of US$0.01. Over recent quarters the company has seen revenue move between US$0 and US$10 million, while quarterly basic EPS ranged from about US$0.00 to US$0.03 in losses. This sets a backdrop where margin pressure rather than sales growth is front and center for investors parsing this update. See our full...

If you are wondering whether PACS Group still offers good value after its strong run, or if most of the opportunity is already reflected in the share price, this article is designed to help you make sense of where the stock stands today. The share price closed at US$35.69, with a 15.3% decline over the last 7 days and a 1.9% decline over 30 days, but a 155.7% return over the past year suggests that the story has been far from quiet. Recent coverage has focused on PACS Group as a listed...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

If you are wondering whether Novavax's share price still reflects its true worth, you are not alone. This article will walk through what the current valuation really says. Over the past month the stock is up 23.1%, even though the 7 day return is a 5.4% decline and the 1 year return sits at a 6.9% loss after much steeper falls of 29.0% over 3 years and 93.6% over 5 years. Recent moves in Novavax shares have been framed by ongoing interest in vaccine related companies and renewed investor...

Why REV Group is on investors’ radar today REV Group (REVG) has drawn fresh attention after recent trading left the stock with mixed short term returns but stronger gains over the month and past 3 months, prompting investors to reassess its valuation. See our latest analysis for REV Group. Despite a 2.1% one-day share price decline and some recent softness over the past week, REV Group’s 30-day share price return of 8.4% and very large 5-year total shareholder return suggest longer-term...

If you are wondering whether ServisFirst Bancshares at around US$76.33 is offering good value right now, you are not alone. This article is set up to help you make sense of that question. The stock has returned 1.6% over the past week and 5.1% over the last 30 days, while the 1 year return of negative 13.6% contrasts with longer term gains of 24.6% over 3 years and 89.1% over 5 years. Recent attention on regional banks, and ServisFirst Bancshares in particular, has centered on how investors...

Elastic (NYSE:ESTC) has rolled out an upgraded Elastic Cloud Serverless platform on Amazon Web Services. The release introduces higher indexing throughput and lower search latency through the use of AWS Graviton instances. The upgrade is live immediately for all AWS based serverless users, with no manual changes required. The company highlights benefits for search, observability, and AI/ML workloads that rely on larger and more complex data volumes. For context, Elastic focuses on search,...

In January 2026, Tenaya Therapeutics outlined past and upcoming 2026 milestones for its TN-201 and TN-401 gene therapy programs, including interim MyPEAK-1 data, additional RIDGE-1 updates, and plans to seek regulatory alignment on potential pivotal studies. A key insight is that both programs target genetically defined cardiac conditions with U.S. FDA designations and planned data readouts that could clarify each therapy’s clinical risk profile and development path. We will now examine how...

If you are trying to work out whether Axcelis Technologies is still a reasonable entry point or already pricing in a lot of good news, its current valuation story is worth a closer look. The share price recently closed at US$88.16, with returns of 6.6% over the last 30 days and 23.4% over the last year, although the stock has seen a 9.2% decline over the past week and an 18.3% decline over three years, with a 135.5% gain over five years and a 2.4% return year to date. Recent coverage has...

As the U.S. market grapples with heightened geopolitical tensions and the threat of new tariffs, major indices like the Nasdaq and S&P 500 have experienced significant declines, reflecting broader market unease. Amidst this volatility, investors often seek stocks with strong fundamentals and innovative potential that can navigate such uncertain environments effectively.

As geopolitical tensions escalate and U.S. markets react to new tariff threats, investors are seeking stability amid heightened volatility. In such uncertain times, identifying stocks that may be trading below their fair value can present opportunities for those looking to capitalize on market inefficiencies.

In the midst of geopolitical tensions and market volatility, as seen with recent tariff threats impacting major indices, investors are increasingly seeking stability in assets with strong fundamentals. In such uncertain times, growth companies with high insider ownership can be particularly appealing, as they often signal confidence from those closest to the company's operations and future prospects.

In the midst of heightened geopolitical tensions and market volatility, as evidenced by recent sharp declines in major U.S. stock indices following tariff threats, investors are increasingly seeking stability through dividend stocks. These stocks can provide a reliable income stream and potential for long-term growth, making them an attractive option during uncertain times.

Despite an already strong run, Day One Biopharmaceuticals, Inc. ( NASDAQ:DAWN ) shares have been powering on, with a...

Unfortunately for some shareholders, the Montauk Renewables, Inc. ( NASDAQ:MNTK ) share price has dived 27% in the last...

GeneDx Holdings Corp. ( NASDAQ:WGS ) shares have had a horrible month, losing 29% after a relatively good period...

The FingerMotion, Inc. ( NASDAQ:FNGR ) share price has fared very poorly over the last month, falling by a substantial...

FTAI Aviation Ltd. ( NASDAQ:FTAI ) shareholders have had their patience rewarded with a 66% share price jump in the...

The Sight Sciences, Inc. ( NASDAQ:SGHT ) share price has softened a substantial 26% over the previous 30 days, handing...

If you are wondering whether Jefferson Capital’s current share price lines up with its underlying value, this article will walk through what the numbers are actually saying. The stock recently closed at US$21.87, with returns of a 6.4% decline over the last 7 days, a 3.1% decline over 30 days, and a 1.1% decline year to date, which may hint at shifting views on its prospects and risk. Recent coverage has focused on Jefferson Capital’s position within the diversified financials space and how...

If you are wondering whether SharkNinja's current share price reflects its true worth, you are not alone. This article will help you frame what the numbers might be telling you about value. SharkNinja's share price recently closed at US$122.78, with returns of 6.5% over the last 30 days, 7.8% year to date, and 11.6% over the past year, alongside a 2.7% decline over the last week. Recent coverage has focused on SharkNinja as a listed consumer durables company and how investors are assessing...

Asana, Inc. ( NYSE:ASAN ) shareholders that were waiting for something to happen have been dealt a blow with a 26...